<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>47</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ikonomidis, I.</style></author><author><style face="normal" font="default" size="100%">Athanassopoulos, G</style></author><author><style face="normal" font="default" size="100%">Stamatelopoulos, K.</style></author><author><style face="normal" font="default" size="100%">Revela, I.</style></author><author><style face="normal" font="default" size="100%">Lekakis, J.</style></author><author><style face="normal" font="default" size="100%">Marinou, M</style></author><author><style face="normal" font="default" size="100%">Venetsanou, K.</style></author><author><style face="normal" font="default" size="100%">Kremastinos, D.</style></author><author><style face="normal" font="default" size="100%">Cokkinos, D</style></author><author><style face="normal" font="default" size="100%">Nihoyannopoulos, P</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Additive prognostic value of interleukin 6 measured at peak phase of dobutamine stress echo in patients with coronary artery disease. A six-year follow-up study</style></title><secondary-title><style face="normal" font="default" size="100%">EUROPEAN HEART JOURNAL</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year></dates><publisher><style face="normal" font="default" size="100%">OXFORD UNIV PRESS GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND</style></publisher><volume><style face="normal" font="default" size="100%">28</style></volume><pages><style face="normal" font="default" size="100%">277–277</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>